Commerzbank Aktiengesellschaft’s Bristol-Myers Squibb BMY Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,000	Closed	-$83K	–	145
2020 Q1	$83K	Buy	+20,000	New	+$1.22M	﹤0.01%	421
2019 Q3	–	Sell	-50,000	Closed	-$3K	–	863
2019 Q2	$3K	Buy	+50,000	New	+$2.33M	﹤0.01%	1050
2019 Q1	–	Sell	-20,000	Closed	-$1K	–	880
2018 Q4	$1K	Hold	20,000	–	–	﹤0.01%	958
2018 Q3	$10K	Hold	20,000	–	–	﹤0.01%	984
2018 Q2	$9K	Hold	20,000	–	–	﹤0.01%	917
2018 Q1	$59K	Buy	+20,000	New	+$1.29M	﹤0.01%	895
2017 Q1	–	Sell	-40,000	Closed	-$2.34M	–	929
2016 Q4	$2.34M	Hold	40,000	–	–	0.03%	326
2016 Q3	$2.16M	Buy	+40,000	New	+$2.57M	0.03%	323
2016 Q2	–	Sell	-40,000	Closed	-$2.56M	–	997
2016 Q1	$2.56M	Hold	40,000	–	–	0.02%	335
2015 Q4	$2.75M	Hold	40,000	–	–	0.02%	415
2015 Q3	$2.37M	Hold	40,000	–	–	0.02%	407
2015 Q2	$2.66M	Hold	40,000	–	–	0.01%	524
2015 Q1	$2.58M	Hold	40,000	–	–	0.02%	540
2014 Q4	$2.36M	Sell	40,000 -68,300	-63%	-$3.85M	0.02%	617
2014 Q3	$5.54M	Sell	108,300 -40,000	-27%	-$2M	0.02%	454
2014 Q2	$7.19M	Sell	148,300 -150,000	-50%	-$7.39M	0.04%	363
2014 Q1	$15.5M	Sell	298,300 -48,907	-14%	-$2.6M	0.07%	183
2013 Q4	$17.4M	Buy	347,207 +238,907	+221%	+$12.2M	0.09%	161
2013 Q3	$5.01M	Sell	108,300 -259,500	-71%	-$11.4M	0.03%	463
2013 Q2	$16.4M	Buy	+367,800	New	+$16M	0.07%	217

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commerzbank Aktiengesellschaft's BMY Position: Q1 2026 in Review

Commerzbank Aktiengesellschaft reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q1 2026, selling an estimated $42.2K and leaving 13,733 shares worth $833K. The position accounts for 0.02% of the portfolio, ranked #221.

Commerzbank Aktiengesellschaft first reported a position in BMY in Q2 2013 and has held it in 37 quarters since. The position peaked at $48.6M in Q4 2019. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Commerzbank Aktiengesellschaft held 13,733 shares of Bristol-Myers Squibb worth $833K as of Q1 2026.
Commerzbank Aktiengesellschaft sold 724 Bristol-Myers Squibb shares in Q1 2026, an estimated $42.2K.
Bristol-Myers Squibb made up 0.02% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #221 holding.
Commerzbank Aktiengesellschaft first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 37 quarters since.
Commerzbank Aktiengesellschaft's Bristol-Myers Squibb position peaked at $48.6M in Q4 2019.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.